934765-62-5

Upstream product

• 78056-39-0 4,5-difluoro-2-nitroaniline 
• 123-08-0 4-hydroxy-benzaldehyde 
• 104222-34-6 2-nitro-4-fluoro-5-chloroaniline 

Downstream Products

• 934765-63-6 1,1-dimethylethyl({4-[(5-amino-2-fluoro-4-nitrophenyl)oxy]phenyl}methyl)(4,4-dimethylcyclohexyl)carbamate 
• 934765-64-7 2,2,2-trifluoro-N-[4-fluoro-5-[(4-formylphenyl)oxy]-2-nitrophenyl]acetamide 

Relevant academic research and scientific papers

Phenazine N,N′-dioxide scaffold as selective hypoxic cytotoxin pharmacophore. Structural modifications looking for further DNA topoisomerase II-inhibition activity

Phenazine-5,10-dioxides have been identified as prodrugs for antitumour therapy that undergo hypoxic-selective bioreduction, in the solid tumour cells, to form cytotoxic species. We investigated structural modifications of the phenazine-5,10-dioxide scaff

NOVEL HETEROCYCLE COMPOUNDS

The present invention relates to novel compounds which are antagonist or inverse agonists at an opioid receptor. Such compounds are useful in the treatment of obesity and related diseases and/or conditions in mammals, particularly humans. Methods of making and using such compounds are also disclosed.